Product Wiki · Recalls · EU Safety Gate (RAPEX)

Hängvagga — recall SR/02141/25

EU Safety Gate (RAPEX) · Sweden · 2025-06-13 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02141/25
Date of alert
2025-06-13
Country / jurisdiction
Sweden
Risk level
Serious risk
Risk type
Injuries, Strangulation, Suffocation
Brand
Moonboon International ApS
Product category
Childcare articles and children's equipment
Product type
Baby hammock
Barcode (EAN/GTIN)
5744001610503
Reported risk: The baby hammock's excessive tilt angle and curved lying surface may cause the child to roll over, become stuck, and suffocate or have their airways obstructed. The product also lacks a safe design, with inadequate side walls that may allow the child to roll out and fall, as well as potentially accessible cords that could lead to strangulation due to imprecise assembly instructions.
Action taken by the authority
Type of economic operator taking notified measure
Retailer
Category of measure
Recall of the product from end users
Date of entry into force
27/05/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Hängvagga

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10094657

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.